Qingdao Begin Period Cash Flow from 2010 to 2025

688139 Stock   35.20  0.00  0.00%   
Qingdao Haier's Begin Period Cash Flow is increasing over the years with slightly volatile fluctuation. Begin Period Cash Flow is expected to dwindle to about 854.5 M. Begin Period Cash Flow is the amount of cash Qingdao Haier Biomedical has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities. View All Fundamentals
 
Begin Period Cash Flow  
First Reported
2010-12-31
Previous Quarter
1.1 B
Current Value
854.5 M
Quarterly Volatility
551.7 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Qingdao Haier financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Qingdao Haier's main balance sheet or income statement drivers, such as Tax Provision of 45.9 M, Net Interest Income of 37.7 M or Interest Expense of 4.2 M, as well as many indicators such as . Qingdao financial statements analysis is a perfect complement when working with Qingdao Haier Valuation or Volatility modules.
  
This module can also supplement various Qingdao Haier Technical models . Check out the analysis of Qingdao Haier Correlation against competitors.

Currently Active Assets on Macroaxis

Other Information on Investing in Qingdao Stock

Qingdao Haier financial ratios help investors to determine whether Qingdao Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Qingdao with respect to the benefits of owning Qingdao Haier security.